The mineralocorticoid receptor in chronic kidney disease-Reference-Cited by-同舟云学术

The mineralocorticoid receptor in chronic kidney disease

Published:2021-12-28 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Barrera‐Chimal Jonatan¹²,Jaisser Frédéric³⁴,Anders Hans‐Joachim⁵

Affiliation:

1. Instituto de Investigaciones Biomédicas Universidad Nacional Autónoma de México, Ciudad Universitaria Mexico City Mexico

2. Laboratorio de Fisiología Cardiovascular y Trasplante Renal Unidad de Investigación UNAM‐INC, Instituto Nacional de Cardiología Ignacio Chávez Mexico City Mexico

3. INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris Paris France

4. Université de Lorraine, INSERM Centre d'Investigations Cliniques‐Plurithématique 1433, UMR 1116, CHRU de Nancy, French‐Clinical Research Infrastructure Network (F‐CRIN) INI‐CRCT Nancy France

5. Medizinische Klinik und Poliklinik IV, LMU Klinikum Munich Germany

Funder

Fondation de France

Deutsche Forschungsgemeinschaft

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15734

Reference120 articles.

1. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

2. Regression of Existing Glomerulosclerosis by Inhibition of Aldosterone

3. The Concise Guide to PHARMACOLOGY 2021/22: Nuclear hormone receptors;Alexander S. P.;British Journal of Pharmacology,2021

4. The Concise Guide to PHARMACOLOGY 2021/22: Introduction and other protein targets;Alexander S. P.;British Journal of Pharmacology,2021

5. The Concise Guide to PHARMACOLOGY 2021/22: Transporters;Alexander S. P.;British Journal of Pharmacology,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human umbilical cord mesenchymal stem cell-derived exosomes mitigate diabetic nephropathy via enhancing M2 macrophages polarization;Heliyon;2024-09

2. Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway;Clinical Science;2024-08

3. A new perspective on proteinuria and drug therapy for diabetic kidney disease;Frontiers in Pharmacology;2024-07-31

4. Roles of distinct nuclear receptors in diabetic cardiomyopathy;Frontiers in Pharmacology;2024-07-24

5. Chronic Kidney Disease: Etiology, Pathophysiology, and Management Strategies to Increase Quality of Life;Chronic Kidney Disease - Novel Insights into Pathophysiology and Treatment;2024-05-09